United States News All stories

OpenAI is preparing to unveil its first physical AI device in late 2026 as it moves beyond software into consumer hardware.

Digital Wealth Partners has selected Two Prime to oversee a $250 million Bitcoin portfolio for institutional and high-net-worth clients.

A Louisiana pension fund has taken a small stake in MicroStrategy as debate grows over its Bitcoin-focused capital strategy.

Magic Eden’s Jack Lu says rising prediction markets signal a new speculation supercycle for crypto and digital assets.

The NYSE is building a blockchain platform that could enable 24/7 trading of tokenised stocks and ETFs.

A Bloomberg Intelligence strategist says Bitcoin risks a prolonged downturn if it cannot sustain support above $100,000.

Tim Draper has doubled down on his Bitcoin outlook, forecasting a surge to $250,000 within the next six months.

Bitcoin weakened as renewed US tariff rhetoric and regulatory uncertainty drove markets into a defensive stance.

Tokenised real-world assets have started 2026 strongly, with total value locked climbing above $21 billion.

Ethereum has bounced from a major trendline as network activity hits record highs despite mixed investor behaviour.

India is pushing for talks on linking BRICS digital currencies to streamline trade and tourism payments across member states.

The SEC’s crypto strategy has shifted dramatically one year after Gary Gensler’s departure under the Trump administration.

Day one delivered chaos and star power, with Aussie wildcard Talia Gibson’s upset, a historic triple-tiebreak epic, and Carlos Alcaraz opening his campaign toward a potential Career Grand Slam.

Bitcoin is holding above $92,000, but weak ETF flows and macro uncertainty are testing traders’ confidence in a market bottom.

U.S. President Donald Trump has escalated his confrontation with European leaders on the eve of the World Economic Forum in Davos, threatening to impose a 200% tariff on French wine and champagne.

ImmunityBio (NASDAQ:IBRX) is moving toward a significant label expansion for its first-in-class immunotherapy, ANKTIVA® (nogapendekin alfa inbakicept), following a pivotal Type B meeting with the U.S. Food and Drug Administration (FDA).

Murphy Oil (NYSE:MUR) announced today that its Civette-1X exploration well offshore Côte d’Ivoire reached total depth but failed to meet commercial thresholds, a result that provides a sober look at the frontier basin even as it confirms a working petroleum system.

In times of uncertainty, we often look for something solid to hold onto. Lately, it seems the world’s investors have decided that “something solid” is, quite literally, gold. 

The metal’s soaring price is more than just a market trend; it's a global barometer of anxiety. 

When faith in currencies, governments, and traditional financial systems begins to waver, we see a familiar flight to the perceived safety of this timeless asset.

Guardant Health (NASDAQ:GH) has secured an expansive multi-year collaboration with Merck (NYSE:MRK) to integrate its high-sensitivity liquid biopsy technology into Merck’s global oncology development program.

Barrick Gold (NYSE:GOLD) has appointed Helen Cai as Senior Executive Vice President and Chief Financial Officer, elevating a high-profile board member to the executive suite as the mining giant navigates a period of record gold prices and shifting global alliances.

CAE (NYSE:CAE) has appointed Ryan McLeod as its next Chief Financial Officer, marking a key leadership change as the flight simulation and training giant shifts its focus from aggressive growth to margin expansion and operational excellence.

IAMGOLD (NYSE:IAG) reported robust preliminary 2025 results on Monday, as the Canadian miner capitalized on all-time high bullion prices and record production at its flagship Côté Gold operation to strengthen its balance sheet.

Westport Fuel Systems (NASDAQ:WPRT) has commenced production at two newly expanded manufacturing hubs in Canada and China, a strategic move to secure its lead in the rapidly accelerating global hydrogen transport sector.

Immuron (NASDAQ:IMRN) achieved record first-half sales for its lead commercial product, Travelan®, reporting a 5% year-over-year increase in global revenue to AUD$4.2 million.